Akebia Therapeutics
AKBA
#9495
Rank
NZ$0.23 B
Marketcap
NZ$0.86
Share price
-4.78%
Change (1 day)
-72.28%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): NZ-$0.28

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.29. In 2025 the company made an earnings per share (EPS) of NZ-$0.03622 an increase over its 2024 EPS that were of NZ-$0.60.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.28673.27%
2025NZ-$0.03622-93.94%
2024NZ-$0.60-16.83%
2023NZ-$0.72-23.7%
2022NZ-$0.94-69.41%
2021NZ-$3.08-38.63%
2020NZ-$5.0217.37%
2019NZ-$4.272.79%
2018NZ-$4.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.10-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.51-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$31.47-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$12.13 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA